Navigation Links
Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome
Date:7/7/2009

products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information. All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct clinical development of LX1032 and preclinical and clinical development of its other potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements. Information identifying such important factors is contained under "Factors Affecting Forward-Looking Statements" and "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2008, as filed with the Securities and Exchange Commission. Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Lexicon Names Ajay Bansal Executive Vice President and Chief Financial Officer
2. Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week
3. Lexicon to Provide Clinical Pipeline Update and Report First Quarter 2009 Financial Results on April 28, 2009
4. Lexicon Pharmaceuticals 2008 Annual Report to Stockholders Available Online
5. Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals
6. Lexicon to Report Fourth Quarter and Full Year 2007 Financial Results on March 6, 2008
7. Lexicon Files Investigational New Drug Application for LX1032 as a Potential Treatment for Carcinoid Syndrome
8. Lexicon Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference
9. Lexicon Pharmaceuticals to Present at the Piper Jaffray 19th Annual Health Care Conference
10. Lexicon Pharmaceuticals Reports 2007 Third Quarter Financial Results
11. Lexicon to Report Third Quarter 2007 Financial Results on October 30, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... PA (PRWEB) January 15, 2014 The Pittcon ... publisher of Food Safety Tech , an e-Journal and ... signed an agreement for the second year for the co-location ... Pittcon 2014. The partnership provides that the registration fee to ... also include unlimited week long admission to the Pittcon exposition ...
(Date:1/15/2014)... Westlake Village, Calif. (PRWEB) January 15, 2014 ... cancer treatment and management through the genomic analysis of ... will offer Therapy Finder™, a web-based cancer decision support ... a reporting option with Cynvenio’s ClearID™ genomic test, Therapy ... with a dynamic resource to navigate and understand both ...
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... Two champions of science, technology, engineering, ... of an annual competition for middle and high ... access to, innovative STEM study. The competition presents ... TEAMS: Tests of Engineering Aptitude, Mathematics, and ... Technology Student Association (TSA). TEAMS provides hands-on STEM ...
Breaking Biology Technology:Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5
... compound in sufficient and rapidly produced yields, potentially ... could boost semiconductor capabilities for large-area applications. , ... the first heterometallic gallium-indium hydroxide nanocluster was the ... of nitrosobenzene. , The substitute was identified during ...
... 31 VNUS(R) Medical,Technologies, Inc. (Nasdaq: VNUS ), ... treatment of venous reflux disease, today,announced the hiring of ... Chief Medical Officer., Dr. Smeets joins VNUS with ... Dr. Smeets served as the Head of Clinical Affairs ...
... RANCHO CORDOVA, Calif., Oct. 31 ThermoGenesis,Corp. (Nasdaq: ... and store adult stem cells, announced today it will ... 30, 2008, on,Thursday, November 6, 2008., Company,s Conference ... call Thursday, November 6, 2008 at,2:00 PM Pacific (5:00 ...
Cached Biology Technology:New nanocluster to boost thin films for semiconductors 2VNUS Medical Technologies, Inc. Announces the Hiring of Guido Smeets, MD, as Vice President of Clinical Research and Chief Medical Officer 2ThermoGenesis Corp. to Announce First Quarter Fiscal 2009 Results on November 6, 2008 2
(Date:4/15/2014)... N.Y. If an insect drew a line as ... be a tangled mess. But there,s method to that ... mechanical engineering and physics, who tries to find simple ... https://cornell.box.com/tbeetle , It turns out the tiger ... optimal reorientation dance as it chases its prey at ...
(Date:4/15/2014)... American Association of Anatomists (AAA) is honored to announce ... presented during the Closing Awards Ceremony being held at ... at 7:30 p.m. during AAA,s 2014 Annual Meeting at ... winners are: , Henry Gray/Elsevier Distinguished Educator ... of Medicine at Mount Sinai, Past-President of the American ...
(Date:4/15/2014)... it has become clear that the genetic code ... addition to the well-known building blocks adenine, cytosine, ... important role. Scientists now assume that the newly ... layer of information that extends and complements the ... umlauts that extend the standard alphabet," explained Professor ...
Breaking Biology News(10 mins):Photo: Tiger beetle's chase highlights mechanical law 2American Association of Anatomists 2014 award winners 2German Research Foundation approves new priority program in the life sciences 2
... a world-leading provider of scientific, technical and medical information ... interactive feature on SciVerse ScienceDirect for applicable life sciences ... displays detailed gene or genomic sequence information on the ... Viewer utilizes a genome browser developed by NCBI (the ...
... algae, build up energy reserves that allow them to survive ... this by means of a molecular switch in an enzyme. ... the excess energy of the bacteria for biotechnological purposes such ... out by researchers at the Ruhr-Universitt led by Prof. Dr. ...
... During the 1970s and 1980s, researchers and policymakers became ... sulfur dioxide and nitrogen oxides from the stacks of ... Europe, there was much concern about the effects on ... some cases strikingly acidic. The Swedish government instituted a ...
Cached Biology News:Elsevier introduces Genome Viewer 2RUB researchers decipher the molecular basis of blue-green algae 2Organic carbon suggests Swedish lakes were less acidified 2
Disposable tips with floating filter (US Patent 6,702,990) for PDM1.5 OneTouch Plus spotpicker, 10 racks of 96, DNAse and RNAse free...
... The new D-LUX Detection Platform ... to provide the most sensitive, specific, ... qPCR. Invitrogens D-LUX Detection Platform offers ... equal to TaqMan probes, high signal/background ...
...
Request Info...
Biology Products: